These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28624604)

  • 1. User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate.
    Chan GCK; Hall W; Freeman TP; Ferris J; Kelly AB; Winstock A
    Drug Alcohol Depend; 2017 Sep; 178():32-38. PubMed ID: 28624604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between butane hash oil use and cannabis-related problems.
    Meier MH
    Drug Alcohol Depend; 2017 Oct; 179():25-31. PubMed ID: 28750253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method of cannabis ingestion: the dangers of dabs?
    Loflin M; Earleywine M
    Addict Behav; 2014 Oct; 39(10):1430-3. PubMed ID: 24930049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys.
    Berberian S; Broussard ML; Tully C; Methuku V; Pardini DA; Meier MH
    J Cannabis Res; 2022 Apr; 4(1):14. PubMed ID: 35365236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado.
    Bell C; Slim J; Flaten HK; Lindberg G; Arek W; Monte AA
    J Med Toxicol; 2015 Dec; 11(4):422-5. PubMed ID: 26289652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.
    Hädener M; Vieten S; Weinmann W; Mahler H
    Forensic Sci Int; 2019 Feb; 295():207-212. PubMed ID: 30638755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A within-person comparison of the subjective effects of higher vs. lower-potency cannabis.
    Okey SA; Meier MH
    Drug Alcohol Depend; 2020 Nov; 216():108225. PubMed ID: 32858319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings.
    Meacham MC; Paul MJ; Ramo DE
    Drug Alcohol Depend; 2018 Jul; 188():364-369. PubMed ID: 29883950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butane Hash Oil Burns: A 7-Year Perspective on a Growing Problem.
    Romanowski KS; Barsun A; Kwan P; Teo EH; Palmieri TL; Sen S; Maguina P; Greenhalgh DG
    J Burn Care Res; 2017; 38(1):e165-e171. PubMed ID: 27058582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Made from concentrate? A national web survey assessing dab use in the United States.
    Sagar KA; Lambros AM; Dahlgren MK; Smith RT; Gruber SA
    Drug Alcohol Depend; 2018 Sep; 190():133-142. PubMed ID: 30029166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls.
    Lawn W; Mokrysz C; Lees R; Trinci K; Petrilli K; Skumlien M; Borissova A; Ofori S; Bird C; Jones G; Bloomfield MA; Das RK; Wall MB; Freeman TP; Curran HV
    J Psychopharmacol; 2022 Dec; 36(12):1350-1361. PubMed ID: 35772419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?
    Varlet V; Concha-Lozano N; Berthet A; Plateel G; Favrat B; De Cesare M; Lauer E; Augsburger M; Thomas A; Giroud C
    Sci Rep; 2016 May; 6():25599. PubMed ID: 27228348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
    Kazour F; Awaida C; Souaiby L; Richa S
    Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Butane Hash Oil Use: A Research Note.
    Miller BL; Stogner JM; Miller JM
    J Psychoactive Drugs; 2016; 48(1):44-9. PubMed ID: 26800050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.